Technology developed to analyze and detect digital biomarkers for early disease detection

The increase in chronic and lifestyle-related diseases requires advances in digital detection through biomarker data to address the growing need for disease management and healthcare transformation.

Want to Read the Full Article?

Posted by Rebecca Harris

Rebecca Moody Harris is a CPA and CFO with over eighteen years of progressive financial experience. For the last twelve years, she has served the healthcare industry in CFO and executive leadership roles. Her experience ranges from large corporations to start-ups in the private sector, and Rebecca specializes in Mergers and Acquisitions, Private Equity fundraising, and computer information systems.

Technology developed to analyze and detect digital biomarkers for early disease detection

Want to Read the Full Article?

Article Topics